| Heart disease and stroke statistics—2017 update: a report from the American Heart Association EJ Benjamin, MJ Blaha, SE Chiuve, M Cushman, SR Das, R Deo, ... circulation 135 (10), e146-e603, 2017 | 41809* | 2017 |
| Heart disease and stroke statistics—2016 update: a report from the American Heart Association D Mozaffarian, EJ Benjamin, AS Go, DK Arnett, MJ Blaha, M Cushman, ... circulation 133 (4), e38-e360, 2016 | 25326* | 2016 |
| Dabigatran versus warfarin in patients with atrial fibrillation SJ Connolly, MD Ezekowitz, S Yusuf, J Eikelboom, J Oldgren, A Parekh, ... New England Journal of Medicine 361 (12), 1139-1151, 2009 | 12805 | 2009 |
| Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation Clopidogrel in Unstable Angina to Prevent Recurrent Events Trial Investigators New England Journal of Medicine 345 (7), 494-502, 2001 | 8177 | 2001 |
| Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. S Yusuf, P Sleight, J Pogue, J Bosch, R Davies, G Dagenais The New England journal of medicine 342 (3), 145-153, 2000 | 8034 | 2000 |
| Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the Atrial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events … HG Site Lancet 367 (9526), 1903-1912, 2006 | 3069* | 2006 |
| Effects of extended-release metoprolol succinate in patients undergoing non-cardiac surgery (POISE trial): a randomised controlled trial POISE Study Group The Lancet 371 (9627), 1839-1847, 2008 | 2292 | 2008 |
| Homocysteine lowering with folic acid and B vitamins in vascular disease Heart Outcomes Prevention Evaluation (HOPE) 2 Investigators New England Journal of Medicine 354 (15), 1567-1577, 2006 | 2174 | 2006 |
| Effect of rosiglitazone on the frequency of diabetes in patients with impaired glucose tolerance or impaired fasting glucose: a randomised controlled trial DREAM (Diabetes REduction Assessment with ramipril and rosiglitazone ... The Lancet 368 (9541), 1096-1105, 2006 | 2127 | 2006 |
| Long-term ACE-inhibitor therapy in patients with heart failure or left-ventricular dysfunction: a systematic overview of data from individual patients MD Flather, S Yusuf, L Køber, M Pfeffer, A Hall, G Murray, ... The Lancet 355 (9215), 1575-1581, 2000 | 2059 | 2000 |
| Vitamin E supplementation and cardiovascular events in high-risk patients. S Yusuf, G Dagenais, J Pogue, J Bosch, P Sleight The New England journal of medicine 342 (3), 154-160, 2000 | 1928 | 2000 |
| Renal outcomes with telmisartan, ramipril, or both, in people at high vascular risk (the ONTARGET study): a multicentre, randomised, double-blind, controlled trial JFE Mann, RE Schmieder, M McQueen, L Dyal, H Schumacher, J Pogue, ... The Lancet 372 (9638), 547-553, 2008 | 1914 | 2008 |
| Basal insulin and cardiovascular and other outcomes in dysglycemia ORIGIN Trial Investigators New England Journal of Medicine 367 (4), 319-328, 2012 | 1779 | 2012 |
| Renal insufficiency as a predictor of cardiovascular outcomes and the impact of ramipril: the HOPE randomized trial JFE Mann, HC Gerstein, J Pogue, J Bosch, S Yusuf, Hope Investigators Annals of internal medicine 134 (8), 629-636, 2001 | 1762 | 2001 |
| Waist circumference and waist-to-hip ratio as predictors of cardiovascular events: meta-regression analysis of prospective studies L De Koning, AT Merchant, J Pogue, SS Anand European heart journal 28 (7), 850-856, 2007 | 1412 | 2007 |
| Comparison of fondaparinux and enoxaparin in acute coronary syndromes Fifth Organization to Assess Strategies in Acute Ischemic Syndromes ... New England Journal of Medicine 354 (14), 1464-1476, 2006 | 1391 | 2006 |
| Effects of long-term vitamin E supplementation on cardiovascular events and cancer: a randomized controlled trial. E Lonn, J Bosch, S Yusuf, P Sheridan, J Pogue, JM Arnold, C Ross, ... Jama 293 (11), 1338-1347, 2005 | 1323 | 2005 |
| Efficacy and safety of dabigatran compared with warfarin at different levels of international normalised ratio control for stroke prevention in atrial fibrillation: an analysis … L Wallentin, S Yusuf, MD Ezekowitz, M Alings, M Flather, MG Franzosi, ... The Lancet 376 (9745), 975-983, 2010 | 1234 | 2010 |
| Comparison of candesartan, enalapril, and their combination in congestive heart failure: randomized evaluation of strategies for left ventricular dysfunction (RESOLVD) pilot … RS McKelvie, S Yusuf, D Pericak, A Avezum, RJ Burns, J Probstfield, ... Circulation 100 (10), 1056-1064, 1999 | 1230 | 1999 |
| Effects of the angiotensin-receptor blocker telmisartan on cardiovascular events in high-risk patients intolerant to angiotensin-converting enzyme inhibitors: a randomised … Telmisartan Randomised AssessmeNt Study in ACE iNtolerant subjects with ... The Lancet 372 (9644), 1174-1183, 2008 | 1115 | 2008 |
Hertzel GersteinMcMaster UniversityBestätigte E-Mail-Adresse bei mcmaster.ca
